Sutro Biopharma Inc.

AI Score

0

Unlock

1.45
-0.14 (-8.81%)
At close: Mar 03, 2025, 3:59 PM

Sutro Biopharma Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -106.79M -119.2M -105.54M -32.13M -55.74M -35.32M -19.69M 1.7M
Depreciation & Amortization 6.82M 5.69M 4.84M 4.3M 4.78M 4.54M 4.99M 5.66M
Stock-Based Compensation 24.91M 26.3M 23.24M 11.92M 10.31M 2.87M 1.39M 968K
Other Working Capital -10.23M 100.29M -12.61M -11.22M -20.45M 44.93M -25.03M -21.98M
Other Non-Cash Items -2.17M -13.65M 6.16M 606K 193K -517K 132K 98K
Deferred Income Tax n/a n/a 7.24M -41.01M -1.3M -1.5M 3M 80K
Change in Working Capital -34.38M 104.41M -17.62M -11.49M -23.26M 42.61M -26.9M -21.66M
Operating Cash Flow -111.62M 3.55M -81.68M -67.8M -65.02M 12.68M -37.07M -13.15M
Capital Expenditures -4.32M -7.86M -15.32M -7.13M -3.48M -1.56M -3.32M -4.39M
Acquisitions n/a 28.74M n/a n/a 47.65M n/a n/a 16K
Purchase of Investments -460.3M -216.67M -248.73M -130.74M -196.23M -81.46M -14.22M -52.3M
Sales Maturities Of Investments 460.69M 189.5M 166.73M 138.38M 148.58M 2.75M 50.06M 66.27M
Other Investing Acitivies n/a -28.73M 9K 89K -47.65M 80K 80K 16K
Investing Cash Flow -3.92M -35.02M -97.31M 604K -51.13M -80.19M 32.6M 9.59M
Debt Repayment -12.5M -9.38M n/a 15M -5M n/a 15M n/a
Common Stock Repurchased n/a n/a -7K n/a -327K n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 138.08M 1.42M 3.26M 2.83M 1.14M 86.35M -362K 177K
Financial Cash Flow 137.55M 48.31M 3.26M 269.25M -4.18M 170.78M 14.64M 177K
Net Cash Flow 22.01M 16.84M -175.74M 202.05M -120.34M 103.28M 10.17M -3.38M
Free Cash Flow -115.93M -4.31M -97M -74.93M -68.5M 11.13M -40.39M -17.55M